Search
Regramostim
go.drugbank.com/drugs/DB05386InvestigationalRegramostim (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages.
Cadexomer iodine
go.drugbank.com/drugs/DB16572InvestigationalCategories: Preparations for Treatment of Wounds and UlcersMeladrazine
go.drugbank.com/drugs/DB13272ExperimentalCategories: Drugs for Urinary Frequency and IncontinenceTrenbolone
go.drugbank.com/drugs/DB11551ExperimentalVet approvedTrenbolone, also known as trienolone or trienbolone, is a steroid used on livestock to increase muscle growth and appetite. … To increase its effective half-life, trenbolone is administered as a prodrug as an ester conjugate such as [trenbolone acetate], trenbolone enanthate, or trenbolone cyclohexylmethylcarbonate.
Bufogenin
go.drugbank.com/drugs/DB19835ExperimentalBufogenin is a small molecule drug. Bufogenin has a monoisotopic molecular weight of 384.23 Da.
Categories: Compounds used in a research, industrial, or household settingDenopamine
go.drugbank.com/drugs/DB21277ExperimentalDenopamine is a small molecule drug. Denopamine has a monoisotopic molecular weight of 317.16 Da.
Categories: Compounds used in a research, industrial, or household settingRocbrutinib
go.drugbank.com/drugs/DB19445InvestigationalRocbrutinib is under investigation in clinical trial NCT05716087 (A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma).
Synonyms: 2-Propenamide, N-[5-[[6-[2-(1,3,4,6,7,8-hexahydro-7,7-dimethyl-1-oxo-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-3-(hydroxymethyl)-4-pyridinyl]-3,4-dihydro-4-methyl-3-oxo-2-pyrazinyl]amino]-2-[(2S)-2, N-[5-[[6-[2-(1,3,4,6,7,8-Hexahydro-7,7-dimethyl-1-oxo-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl)-3-(hydroxymethyl)-4-pyridinyl]-3,4-dihydro-4-methyl-3-oxo-2-pyrazinyl]amino]-2-[(2S)-2-methyl-4-(tetrahydroBMS-599626
go.drugbank.com/drugs/DB12318InvestigationalBMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
Codrituzumab
go.drugbank.com/drugs/DB14843InvestigationalCodrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).